In Vitro Cultivation and Development of Cryptosporidium in Cell Culture

Cryptosporidium: From Molecules to Disease

Volumn , Issue , 2003, Pages 233-253

  Hijjawi, Nawal ^a,b  

^a MURDOCH UNIVERSITY   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2442580661     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044451351-9/50034-3     Document Type: Chapter

References (112)

1. Adams R.B., Guerrant R.L., Zu S., Fang G., Roche J.K. Cryptosporidium parvum infection of intestinal epithelium: morphologic and functional studies in an in vitro model. J. Inf. Dis. 1994, 169:170.
2. Aji T., Flanigan T., Marshall R., Kaetzel C., Aikawa M. Ultrastructural study of asexual development of Cryptosporidium in a human intestinal cell line. J. Protozool. 1991, 38:82s.
3. Armson A., Meloni B.P., Reynoldson J.A., Thompson R.C.A. Assessment of drugs against Cryptosporidium parvum using a simple in vitro screening method. FEMS Microbiol. Lett. 1999, 178:227-233.
4. Armson A., Sargent K., Mac Donald L.M., Finn M.P., Thompson R.C.A., Reynoldson J.A. A comparison of the effects of two dinitroanilines against Cryptosporidium parvum in vitro and in vivo in neonatal mice and rats. FEMS Immunol. Med. Microbiol. 1999, 26:109-113.
5. Arrowood M.J., Ti Xie L., Hurd M. In vitro assays of Maduramiacin activity against Cryptosporidium parvum. J. Euk. Microbiol. 1994, 41:23s.
6. Arrowood M.J., Mead J.R., Xie L., You X. In vitro anticryptosporidial activity of dinitroaniline herbicides. FEMS Microbiol. Lett. 1996, 136:245-249.
7. Bonnin A., Salimbeni I., Dubremetz J.F., Harly G., Chavanet P., Camerlynck P. Mise au point d'une modele experimental de culture in vitro de stades asexues de Cryptosporidium sp. Annales de Parasitologie Humaine et Comparee 1990, 65:41.
8. Buraud M., Forget E., Favennec L., Bizet J., Gobert J., Deluol A. Sexual stages of development of Cryptosporidia in the Caco-2 cell line. Inf. Immunol. 1991, 59:4610.
9. Cama V.A., Ortega Y.R., Sterling C.R. In vitro evaluation of Clarithromycin, 14-OH Clarithromycin and Paramomycin against Cryptosporidium parvum infectivity [Abstract]. Proceedings of The 95th Annual Meeting of the Society for Microbiology 1995, 164.
10. Campbell A.T., Robertson L.J., Smith H.V. Viability of Cryptosporidium parvum oocysts: correlation of in vitro excystation with inclusion or exclusion of fluorogenic vital dyes. Appl. Environ. Microbiol. 1992, 58:3488-3493.
11. Carreno R.A., Pokorny N.J., Weir S.C., Lee H., Trevors J.T. Decrease in Cryptosporidium parvum oocyst infectivity in vitro by using the membrane filter dissolution method for recovering oocysts from water samples. Appl. Environ. Microbiol. 2001, 67:3309-3313.
12. CiFuentes J., Rosales M.J., Diaz J., Osuna A., Boy M., Mascaro C. Au sujet de la culture in vitro de Cryptosporidium parvum. J. Protozool. 1991, 38:24A.
13. Current W.L. Cryptosporidium sp. in chickens: Parasite life cycle and aspects of acquired immunity. Research in Avian coccidiosis. Proceedings of the Georgia Coccidiosis Conference 1986, 124. University of Georgia, Athens. L.R. McDougal, L.P. Joyner, P.L. Long (Eds.).
14. Current W.L. Technique and laboratory maintenance of Cryptosporidium. Chapter 2. Cryptosporidiosis of Man and animals 1990, 31-49. CRC Press, Florida. R. Fayer, J.P. Dubey, C.A. Speer (Eds.).
15. Current W.L., Garcia L.S. Cryptosporidiosis. Clin. Microbiol. Rev. 1991, 4:325-358.
16. Current W.L., Haynes T.B. Complete development of Cryptosporidium in cell culture. Science 1984, 224:603-605.
17. Current W.L., Long P.L. Development of human and calf Cryptosporidium in chicken embryos. J. Inf. Dis. 1983, 148:1108.
18. Datry A., Danis M., Gentilini M. Development complet de Cryptosporidium en culture cellulaire: applications. Med. Sc. 1989, 5:762-766.
19. Deng M.Q., Cliver D.O. Cryptosporidium parvum development in the BS-C-1 cell line. J. Parasitol 1998, 84:8-15.
20. Di Giovanni G.D., Hashemi F.H., Shaw N.J., Abrams F.A., Lechevallier M.W., Abbaszadegan M. Detection of infectious Cryptosporidium parvum oocysts in surface and filter backwash water samples by immunomagnetic separation and integrated cell culture-PCR. Appl. Environ. Microbiol. 1999, 65:3427-3432.
21. Doran D.J. Increasing the yield of Eimeria tenella oocysts in cell culture. J. Parasitol. 1971, 57:891-900.
22. Doran D.J., Vetterling J.M., Augustine P.C. Eimeria tenella: an in vivo and in vitro comparison of the Wisconsin, Weybridge, and Beltsville strains. Proc. Helminthol. Soc. Washington 1974, 41:77.
23. Doyle P.S., Crabb J., Petersen C. Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo. Inf. Immunol. 1993, 61:4079.
24. Dvorak J., Crane M.S.J. Vertebrate cell cycle modulates infection by protozoan parasites. Science 1981, 214:1034.
25. Dvorak J., Howe C. Toxoplasma gondii-vertebrate cell interaction. I. The influence of bicarbonate ion, CO2, pH and host cell culture age on the invasion of vertebrate cells in vitro. J. Protozool. 1977, 24:416.
26. Eggleston M.T., Tilley M., Upton S.J. Enhanced development of Cryptosporidium parvum in vitro by removal of oocyst toxins from infected cell monolayers. Proc. Helminthol. Soc. Washington 1994, 61:118-121.
27. Fayer R., Leek R.G. The effects of reducing conditions, medium, pH, temperature and time on in vitro excystation of Cryptosporidium. J. Protozool. 1984, 31:567-569.
28. Fayer R., Nerad T. Effects of low temperature on viability of Cryptosporidium parvum oocysts. Appl. Environ. Microbiol. 1996, 62:1431-1433.
29. Fayer R., Unger B.L. Cryptosporidium spp. and Cryptosporidiosis. Microbiol. Rev. 1986, 50:458-483.
30. Fayer R., Andrews C., Ungar B.L., Blagburn B. Efficacy of hyperimmune bovine colostrum for the prophylaxis of cryptosporidiosis in neonatal calves. J. Parasitol. 1989, 75:393-397.
31. Fayer R., Dubey J.P., Speer C.A. General biology of Cryptosporidium. Cryptosporidiosis of Man and Animals 1990, 1-29. CRC Press, Florida. R. Fayer, J.P. Dubey, C.A. Speer (Eds.).
32. Fayer R., Nerad T., Rall W., Lindsay D.S., Blagburn B.L. Studies on cryopreservation of Cryptosporidium parvum. J. Parasitol. 1991, 77:357-361.
33. Fayer R., Speer C.A., Dubey J.P. The general biology of Cryptosporidium. Cryptosporidium and Cryptosporidiosis 1997, 1-41. CRC Press, Florida. R. Fayer (Ed.).
34. Fayer R., Trout J.M., Jenkins M.C. Infectivity of Cryptosporidium parvum oocysts stored in water at environmental temperature. J. Parasitol. 1998, 84:1165-1169.
35. Fayer R., Lewis E.J., Trout J.M., Farley C.A. Cryptosporidium oocysts in oysters from commercial harvesting sites in the Chesapeak Bay. Emerg. Inf. Dis. 1999, 5:706-710.
36. Fayer R., Morgan N.M., Upton S.J. Epidemiology of Cryptosporidium parvum: transmission, detection and identification. Int. J. Parasitol. 2000, 30:1305-1322.
37. Fayer R., Trout J.M., Xiao L., Morgan U.M., Lai A.A., Dubey J.P. Cryptosporidium canis n. sp. from domestic dogs. J. Parasitol. 2001, 87:1415-1422.
38. Favennec L. Physiopathological and therapeutic studies in in vitro and in vivo models of Cryptosporidium parvum infection. J. Euk. Microbiol. 1997, 44:69s-70s.
39. Favennec L., Egraz-Bernard M., Comby E., Lemeteil D., Ballet J.J., Brasseur P. Immunofluorescence detection of Cryptosporidium parvum in Caco-2 cell: a new screening method for anticryptosporidial agents. J. Euk. Microbiol. 1994, 41:39s.
40. Flanigan T.B., Aji T., Marshall R., Aikawa M., Kaetzel C. Cryptosporidium development from sporozoites to schizont in vitro [Abstract WS44]. Proceedings of The 44th Annual Meeting of The Society of Protozoologists 1991, 53. Allen Press, Lawrence.
41. Flanigan T.P., Marshall R., Unger B., Kaetzel C. In vitro screening of immunological and pharmacological therapies against Cryptosporidium [Abstract WS 106]. Proceedings of The 44th Annual Meeting of the Society of Protozoologists 1991, 63. Allen Press, Lawrence.
42. Forney J.R., Yang S., Healy M.C. Protease activity associated with excystation of Cryptosporidium oocyst. J. Parasitol. 1996, 82:889-892.
43. Forney J.R., Vaughan D.K., Yang S., Healey M.C. Actin-dependent motility in Cryptosporidium parvum sporozoites. J. Parasitol. 1998, 84:908-913.
44. Gargala G., Delaunay A., Li X., Braseur P., Favennec L., Ballet J.J. Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells. J. Antimicro. Chemo. 2000, 46:57-60.
45. Giacometti A., Cirioni O., Barchiesi F., Anacarani F., Scalise G. Activity of nitazoxanide alone and in combination with azithromycin and against Cryptosporidium parvum in cell culture. J. Antimicro. Chemo. 2000, 45:453-456.
46. Giacometti A., Cirioni O., Barchiesi F., Scalise G. Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. J. Antimicro. Chemo. 2000, 45:375-377.
47. Giacometti A., Cirioni O., Del Prete M.S., Barchiesi F., Fineo A., Scalise G. Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. J. Antimicro. Chemo. 2001, 47:97-99.
48. Gold D., Stein B., Tzipori S. The utilization of sodium taurocholate in excystation of Cryptosporidium parvum and infection of tissue culture. J. Parasitol. 2001, 87:997-1000.
49. Griffiths J.K., Moore R., Dooley S., Keusch G.T., Tzipori S. Cryptosporidium parvum infection in Caco-2 cell monolayers induce an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death. Inf. Immunol. 1994, 62:4506.
50. Gut J., Nelson R.G. Cryptosporidium parvum sporozoites deposit trail of 11A5 antigen during gliding locomotion and shed 11A5 antigen during invasion of MDCK cells in vitro. J. Euk. Microbiol. 1994, 41. 42s.
51. Gut J., Nelson R.G. Cryptosporidium parvum: Synchronized excystation in vitro and evaluation of sporozoite infectivity with a new lectin-based assay. J. Euk. Microbiol. 1999, 46. 56s.
52. Gut J., Nelson R.G. Cryptosporidium parvum: Lectins mediate irreversible inhibition of sporozoite infectivity in vitro. J. Euk. Microbiol. 1999, 46:29s-48s.
53. Gut J., Petersen C., Nelson R.G., Leech J. Cryptosporidium parvum: in vitro cultivation in Madin-Darby Canine Kidney cells. J. Protozool. 1991, 38. 72S.
54. Hamer D.H., Ward H., Tzipori S., Pereira M.E.A., Alory J.P., Keusch G.T. Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro. Inf. Immunol. 1994, 62:2208.
55. Joe A., Hamer D.H., Kelley M.A., Pereira M.E.A., Keusch G.T., Tizipori S., Ward H.D. Role of a gal/gal NAC-specific sporozoite surface lectin in Cryptosporidium parvum-host cell interaction. J. Euk. Microbiol. 1994, 41. 44s.
56. Jones D.E., TuTu D., Sweeney R.W., Clark D.P. Isolation of Cryptosporidium and Bovine cDNA clones from a Cryptosporidium-infected MDBK cell line substraction library. J. Euk. Microbiol. 1994, 41. 46s.
57. Jenkins M.B., Anguish L.J., Bowman D.D., Walker M.J., Ghiorse W.C. Assessment of a dye permeability assay for the determination of inactivation rates of Cryptosporidium parvum oocysts. Appl. Environ. Microbiol. 1997, 63:3844-3850.
58. Jenkins M., Trout J., Fayer R. A semi-quantitative method for measuring Cryptosporidium parvum infection using polymerase chain reaction. J. Microbiol. Methods 1997, 28:99-107.
59. Jenkins M., Trout J., Fayer R. Development and application of an improved semiquantitative technique for detecting low-level Cryptosporidium parvum infections in mouse tissue using polymerase chain reaction. J. Parasitol. 1998, 84:182-186.
60. Kato S., Jenkins M.B., Ghiorse W.C., Bowman D.D. Chemical and physical factors affecting the excystation of Cryptosporidium parvum oocysts. J. Parasitol. 2001, 87:575-581.
61. Keegan A.R., Gelonese S., Monis P., Saint C.P. The use of culture for the assessment of disinfection methods for Cryptosporidium parvum [Abstract 39]. Cryptosporidium from molecules to disease 2001, Fremantle, Western Australia.
62. Kim H.C., Healy M.C. Infectivity of Cryptosporidium parvum oocysts following cryopreservation. J. Parasitol. 2001, 87:1191-1194.
63. Kuhls T.L., Mosier D.A., Crawford D.L. Effects of carbohydrates (CHOs) and lectins (lecs) on Cryptosporidium sporozoite penetration of cultured cell monolayers [Abstract WS41]. Proceedings of the 44th Annual Meeting of The Society of Protozoologists 1991, 52. Allen Press, Lawrence.
64. Lawton P., Naciri M., Mancassola R., Petavy A. In vitro cultivation of Cryptosporidium parvum in the non-adherent human monocytic THP-1 cell line. J. Euk. Microbiol. 1997, 6:44.
65. Lindsay D.S., Sundermann C.A., Blagburn B.L. Cultivation of Cryptosporidium baileyi: studies with cell cultures, avian embryos, and pathogenicity of chicken embryo-passaged oocysts. J. Parasitol. 1988, 74:288.
66. Lindsay D.S., Woods K.M., Upton S.J., Blagburn B.L. Activity of decoguinte against Cryptosporidium parvum in cell cultures and neonatal mice. Vet. Parasitol. 2000, 89:307-311.
67. Lumb R., Smith K., O'Donoghue P.J., Lanser J.A. Ultrastructure of the attachment of Cryptosporidium sporozoites to tissue culture cells. Parasitol. Res. 1988, 74:531-536.
68. MacDonald L.M., Sargent K., Armson A., Thompson R.C.A., Reynoldson J.A. The development of a real-time quantitative PCR method for the characterisation of a Cryptosporidium parvum in vitro culturing system and assessment of drug efficacy. Mol. Biochem. Parasitol. 2002, 121:279-282.
69. Maillot C., Favennec L., Francois A., Ducrotte P., Brasseur P. Sexual and asexual development of Cryptosporidium parvum in five oocyst-or infected human enterocytic cell lines. J. Euk. Microbiol. 1997, 44:582-585.
70. Marshall R.J., Flanigan T.P. Paromomycin inhibits Cryptosporidium infection of a human enterocyte cell line. J. Infect. Dis. 1992, 165:772-774.
71. Martinez F., Mascaro C., Rosales M.J., Diaz J., Cifuentes J., Osuna A. In vitro multiplication of Cryptosporidium parvum in mouse peritoneal macrophages. Vet. Parasitol. 1992, 42:27.
72. McDonald V., Stables R., warhurst D.C., Barer M.R., Blewett D.A., Chapman H.D., Connolly G.M., Chiodini P.L., McAdam K.P. In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs. Antimicro. Agents and Chemo. 1990, 34:1498.
73. Meloni B.P., Thompson R.C.A. Simplified method for obtaining purified oocysts from mice and growing Cryptosporidium parvum in vitro. J. Parasitol. 1996, 82:757-762.
74. Morgan U.M., Monis P.T., Fayer R., Deplazes P., Thompson R.C.A. Phylogenetic relationships among isolates of Cryptosporidium: evidence for several new species. J. Parasitol. 1999, 85:1126-1133.
75. Naciri M., Yvore P., de Bossieu C., Esnault E. Multiplication de Cryptosporidium muris (Tyzzer 1907) in vitro entreitien d'une souche sur oeufs embryonnes. Recueil de Medecine Veterinaire 1986, 162:51-56.
76. Oretega Y.R., Sterling C.R. Improvements to the in vitro cultivation of Cryptosporidium parvum [Abstract]. Proceedings of The 47th Annual Meeting of The Society for Protozoologists 1994, 79. Allen Press, Lawrence.
77. Pezzani B.C., Bautista E., Cordoba A., De Luca M.M., Basualdo J.A. Factors affecting the in vitro excystation of Cryptosporidium sp. Revista Argentina de Microbiologia 1998, 30:138-142.
78. Pozio E., Morales M.A.G., Barbieri F.M., LaRosa G. Cryptosporidium: different behaviour in calves of isolates of human origin. Trans. Roy. Soc. Trop. Med. Hyg. 1992, 86:636-638.
79. Rasmussen K.R., Larsen N.C., Healey M.C. Complete development of Cryptosporidium parvum in a human endometrial carcinoma cell line. Infect. Immunol. 1993, 61:1482.
80. Reduker D.W., Speer C.A. Factors influencing excystation in Cryptosporidium oocysts from cattle. J. Parasitol. 1985, 71:112-115.
81. Reduker D.W., Spper C.A., Blixt J.A. Ultrastructural changes in the oocyst wall during excystation of Cryptosporidium parvum (Apicomplexa; Eucoccidiorida). Can. J. Zool. 1985, 63:1892-1896.
82. Robertson L.J., Campbell A.T., Smith H.V. In vitro excystation of Cryptosporidium parvum. Parasitology 1993, 106:13-19.
83. Rochelle P.A., De Leon R. Measuring inactivation of Cryptosporidium parvum by in vitro cell culture [Abstract]. Cryptosporidium from molecules to disease 2001, Fremantle, Western Australia.
84. Rochelle P.A., Ferguson D.M., Handojo T.J., De Leon R., Stewart M.H., Wolfe R.L. Development of rapid detection procedure for Cryptosporidium using in vitro cell culture combined with PCR. J. Euk. Microbiol. 1996, 43. 72s.
85. Rochelle P.A., De Leon R., Johnson A., Stewart M.H., Wolfe R.L. Evaluation of immunomagnatic separation for the recovery of infectious Cryptosporidium parvum oocysts from environmental samples. Appl. Environ. Microbiol. 1999, 65:841-845.
86. Rosales M.J., Cifuentes J., Mascaro C. Cryptosporidium parvum: culture in MDCK cells. Exp. Parasitol. 1993, 76:209.
87. Schmatz D.M., Murray P.K. Cultivation of Trypanosoma cruzi in irradiated muscle cells: improved synchronization and enhanced trypomastigote production. Parasitology 1982, 85:115-125.
88. Slifko T., Friedman D., Rose J., Jakubowsi W. An in vitro model for detecting infectious Cryptosporidium oocysts with cell culture. Appl. Environ. Microbiol. 1997, 63:3669-3675.
89. Slifko T.R., Raghubeer E., Rose J.B. Effect of high hydrostatic pressure on Cryptosporidium parvum infectivity. J. Food Protect. 2000, 63:1262-1267.
90. Theodos C.M., Griffiths J.K., D'onfro J., Fairfield A., Tzipori S. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicro. Agents Chemo. 1998, 42:1959-1965.
91. Upton S.J. In vitro cultivation. Cryptosporidiosis of humans and animals 1997, 181-207. CRC Press, Florida. R. Fayer (Ed.).
92. Upton S.J., Tilley M., Mitschler R.R., Oppert B.S. Incorporation of exogenous uracil by Cryptosporidium parvum in vitro. J. Clin. Microbiol. 1991, 29:1062.
93. Upton S.J., Tilley M., Nesterenko M.V., Brillhart D.B. A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa). FEMS Microbiol. Lett. 1994, 118:54.
94. Upton S.J., Tilley M., Brillhart D.B. Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines. FEMS Microbiol. Lett. 1994, 118:233.
95. Upton S.J., Tilley M., Brillhart D.B. Comparative development of Cryptosporidium parvum in MDBK and HCT-8 cells under select atmospheres. Biomed. Lett. 1994, 49:265.
96. Upton S.J., Tilley M., Brillhart D.B. Effects of select medium supplements on the in vitro development of Cryptosporidium parvum in HCT-8 cells. J. Clin. Microbiol. 1995, 33:371-375.
97. Verdon R., Keusch G.T., Tzipori S., Graubman A., Jefferson D.M., Ward H.D. An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum. J. Infect. Dis. 1997, 175:1268-1271.
98. Villacorta I., Graaf D., Charlier G., Peeters J.E. Complete development of Cryptosporidium parvum in MDBK cells. FEMS Microbiol. Lett. 1996, 142:129-132.
99. Walker M.J., Montemagno C., Bryant J.C., Ghiorse W.C. Method detection limits of PCR and immunofluorescence assay for Cryptosporidium parvum in soil. Appl. Environ. Microbiol. 1998, 64:2281-2283.
100. Wanger E.D., Prabhu D.M. Cryptosporidium in cell culture. Jap. J. Parasitol. 1986, 35:253.
101. Widmer G., Corey E.A., Stein B., Griffiths J.K., Tzipori S. Host cell apoptosis impairs Cryptosporidium parvum in vitro. J. Parasitol. 2000, 86:922-928.
102. Wiest P.M., Johnson J.H., Flanigan J.B. Microtubule inhibitors block Cryptosporidium parvum infection of a human enterocyte cell line. Infect. Immunol. 1993, 61:4888.
103. Woodmansee D.B. Isolation, in vitro excystation, and in vitro development of Cryptosporidium sp from calves. Ph.D. dissertation 1986, Iowa State University.
104. Woodmansee D.B. Studies of in vitro excystation of Cryptosporidium parvum from calves. J. Protozool. 1987, 34:398-402.
105. Woodmansee D.B., Pohlenz J.F. Development of Cryptosporidium sp. in a human rectal tumour cell line. Proceedings of The 4th International Symposium on Neonatal Diarrhea 1983.
106. Woods K.M., Upton S.J. Efficacy of select antivirals against Cryptosporidium parvum in vitro. FEMS Microbiol. Lett. 1998, 168:59-63.
107. Woods K.M., Nesterenko M.V., Upton S.J. Development of a microtiter ELISA to quantify development of Cryptosporidium parvum in vitro. FEMS Microbiol. Lett. 1995, 128:89.
108. Xiao L.H., Bern C., Limor J., Sulaiman I., Roberts J., Checkley W., Cabrera L., Gilman R.H., Lal A.A. Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J. Infect. Dis. 2001, 183:492-497.
109. Yang S., Healey M.C., Du C., Zhang J. Complete development of Cryptosporidium parvum in bovine fallopian tube epithelial cells. Infect. Immunol. 1996, 64:349.
110. You X., Arrowood M.J., Lejkowski M., Xie L., Schinazi R.F., Mead J.R. A chemiluminescence immunoassay for the evaluation of Cryptosporidium parvum growth in vitro. FEMS Microbiol. Lett. 1996, 136:251-256.
111. You X., Arrowood M., Lejkowski M., Schinazi R.F., Mead J.R. In vitro evaluation of anticryptosporidial agents using MDCK cell culture and chemiluminescence immunoassay. J. Euk. Microbiol. 1996, 43. 87s.
112. Yu J.R., Choi S.D., Kim Y.W. In vitro infection of Cryptosporidium parvum to four different cell lines. Korean J. Parasitol. 2000, 38:59-64.